+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pneumonia Therapeutics Market by Therapeutics and by Distribution Channel: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025

  • ID: 4853957
  • Report
  • March 2019
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers a forecast and an analysis of the pneumonia therapeutics market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the pneumonia therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pneumonia therapeutics market on a global level.

This report offers a comprehensive view of the global pneumonia therapeutics market along with market trends, drivers, and restraints. This report includes a detailed competitive scenario and portfolio of the key vendors. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the pneumonia therapeutics market by segmenting it based on therapeutics, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. By therapeutics, the market includes prevention vaccines and treatment drugs. The distribution channel segment includes hospital pharmacy, retail pharmacy, and online pharmacy. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into the U.S., Canada, Germany, UK, France, China, Italy, Japan, India, and Brazil.

Some key participants operating in the global pneumonia therapeutics market include GlaxoSmithKline, Sanofi, Merck & Co. Inc., Novartis AG, Eli Lilly and Company, AstraZeneca, Merck & Co., Pfizer, Baxter International Inc., Allergan, and Lupin Pharmaceuticals Inc., among others.

This report segments the global pneumonia therapeutics market into:

Global Pneumonia Therapeutics Market: Therapeutics Analysis

  • Prevention Vaccines
  • Treatment Drugs

Global Pneumonia Therapeutics Market: Distribution Channel Analysis

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

Global Pneumonia Therapeutics Market: Regional Analysis

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Pneumonia Therapeutics Market, 2016-2025 (USD Billion)
    • 2.2. Global Pneumonia Therapeutics Market: Snapshot
  • Chapter 3. Pneumonia Therapeutics Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Increasing Prevalence Of Pneumococcal Disease
      • 3.3.2. Increasing Awareness
    • 3.4. Global Pneumonia Therapeutics market Restraints: Impact Analysis
      • 3.4.1. Very low therapy accessibility
    • 3.5. Opportunities
      • 3.5.1. Untapped Market
    • 3.6. Porter's Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. The Threat From New Entrants
      • 3.6.4. The threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, by Therapeutics
      • 3.7.2. Market Attractiveness Analysis, by Region
  • Chapter 4. Global Pneumonia Therapeutics market - Competitive Landscape
    • 4.1. Company Market Share, 2018 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Source Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research And Development and Regional Expansion
  • Chapter 5. Global Pneumonia Therapeutics market - Therapeutics Analysis
    • 5.1. Global Pneumonia Therapeutics market: Therapeutics Overview
      • 5.1.1. Global Pneumonia Therapeutics Market Revenue Share, By Therapeutics, 2018 and 2025
    • 5.2. Prevention Vaccines
      • 5.2.1. Global Pneumonia Therapeutics market for Prevention Vaccines, 2016-2025 (USD Billion)
    • 5.3. Treatment Drugs
      • 5.3.1. Global Pneumonia Therapeutics market for Treatment Drugs, 2016-2025 (USD Billion)
  • Chapter 6. Global Pneumonia Therapeutics market - Distribution Channel Analysis
    • 6.1. Global Pneumonia Therapeutics market: Distribution Channel Overview
      • 6.1.1. Global Pneumonia Therapeutics Market Revenue Share, By Distribution Channel, 2018 and 2025
    • 6.2. Hospital Pharmacy
      • 6.2.1. Global Pneumonia Therapeutics market for Hospital Pharmacy, 2016-2025 (USD Billion)
    • 6.3. Retail Pharmacy
      • 6.3.1. Global Pneumonia Therapeutics market for Retail Pharmacy, 2016-2025 (USD Billion)
    • 6.4. Online Pharmacy
      • 6.4.1. Global Pneumonia Therapeutics market for Online Pharmacy, 2016-2025 (USD Billion)
  • Chapter 7. Global Pneumonia Therapeutics Market: Regional overview
    • 7.1.. Global Pneumonia Therapeutics Market revenue share, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.2.2. North America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.2.3.2. The U.S. Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.2.4. Rest of North America
        • 7.2.4.1. Rest of North America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.2.4.2. Rest of North America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.3.2. Europe Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.3. UK
        • 7.3.3.1. UK Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.3.2. UK Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.4.2. Germany Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.5.2. France Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.6. Rest of Europe
        • 7.3.6.1. Rest of Europe Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.6.2. Rest of Europe Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.4.2. Asia Pacific Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.3.2. China Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.4.2. Japan Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.5.2. India Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.6. Rest of Asia Pacific
        • 7.4.6.1. Rest of Asia Pacific Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.6.2. Rest of Asia Pacific Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.5.2. Latin America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.5.3.2. Brazil Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.5.4.2. Rest of Latin America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.6.2. The Middle East and Africa Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. GlaxoSmithKline
      • 8.1.1. Overview
      • 8.1.2. Financial overview
      • 8.1.3. Therapeutics Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Merck & Co.
      • 8.2.1. Overview
      • 8.2.2. Financial Overview
      • 8.2.3. Therapeutics Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Novartis AG
      • 8.3.1. Overview
      • 8.3.2. Financial Overview
      • 8.3.3. Therapeutics Portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent Developments
    • 8.4. Sanofi
      • 8.4.1. Overview
      • 8.4.2. Financial Overview
      • 8.4.3. Therapeutics Portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent Developments
    • 8.5. Eli Lilly and Company
      • 8.5.1. Overview
      • 8.5.2. Financial Overview
      • 8.5.3. Therapeutics Portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent Developments
    • 8.6. AstraZeneca
      • 8.6.1. Overview
      • 8.6.2. Financial Overview
      • 8.6.3. Therapeutics Portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent Developments
    • 8.7. Pfizer
      • 8.7.1. Overview
      • 8.7.2. Financial Overview
      • 8.7.3. Therapeutics Portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent Developments
    • 8.8. Baxter International Inc.
      • 8.8.1. Overview
      • 8.8.2. Financial Overview
      • 8.8.3. Therapeutics Portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent Developments
    • 8.9. Lupin Pharmaceuticals Inc.
      • 8.9.1. Overview
      • 8.9.2. Financial Overview
      • 8.9.3. Therapeutics Portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent Developments
    • 8.10. Allergan
      • 8.10.1. Overview
      • 8.10.2. Financial Overview
      • 8.10.3. Therapeutics Portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent Developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll